nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—ABCB1—Ticagrelor—coronary artery disease	0.0632	0.13	CbGbCtD
Terazosin—ABCB1—Perindopril—coronary artery disease	0.0391	0.0806	CbGbCtD
Terazosin—ABCB1—Clopidogrel—coronary artery disease	0.0391	0.0806	CbGbCtD
Terazosin—ABCB1—Pitavastatin—coronary artery disease	0.0342	0.0704	CbGbCtD
Terazosin—ABCB1—Telmisartan—coronary artery disease	0.0342	0.0704	CbGbCtD
Terazosin—ABCB1—Enalapril—coronary artery disease	0.0324	0.0667	CbGbCtD
Terazosin—ABCB1—Lisinopril—coronary artery disease	0.0324	0.0667	CbGbCtD
Terazosin—KCNH2—purkinje fiber—coronary artery disease	0.0312	0.552	CbGeAlD
Terazosin—ABCB1—Timolol—coronary artery disease	0.0275	0.0568	CbGbCtD
Terazosin—ABCB1—Ezetimibe—coronary artery disease	0.0252	0.0519	CbGbCtD
Terazosin—ABCB1—Acetylsalicylic acid—coronary artery disease	0.0245	0.0506	CbGbCtD
Terazosin—ABCB1—Captopril—coronary artery disease	0.0242	0.05	CbGbCtD
Terazosin—ABCB1—Simvastatin—coronary artery disease	0.0234	0.0483	CbGbCtD
Terazosin—ABCB1—Lovastatin—coronary artery disease	0.0229	0.0472	CbGbCtD
Terazosin—ABCB1—Pravastatin—coronary artery disease	0.0229	0.0472	CbGbCtD
Terazosin—ABCB1—Atorvastatin—coronary artery disease	0.0209	0.043	CbGbCtD
Terazosin—ABCB1—Losartan—coronary artery disease	0.0191	0.0393	CbGbCtD
Terazosin—KCNH2—endocardium—coronary artery disease	0.0161	0.284	CbGeAlD
Terazosin—Prazosin—SLC22A3—coronary artery disease	0.00192	0.701	CrCbGaD
Terazosin—KCNH2—cardiac ventricle—coronary artery disease	0.00135	0.0239	CbGeAlD
Terazosin—KCNH2—myocardium—coronary artery disease	0.00127	0.0225	CbGeAlD
Terazosin—ADRA1A—heart—coronary artery disease	0.000919	0.0163	CbGeAlD
Terazosin—KCNH2—heart—coronary artery disease	0.000887	0.0157	CbGeAlD
Terazosin—ADRA1A—cardiovascular system—coronary artery disease	0.000867	0.0153	CbGeAlD
Terazosin—KCNH2—cardiovascular system—coronary artery disease	0.000837	0.0148	CbGeAlD
Terazosin—Doxazosin—CYP2C19—coronary artery disease	0.000822	0.3	CrCbGaD
Terazosin—KCNH2—cardiac atrium—coronary artery disease	0.000759	0.0134	CbGeAlD
Terazosin—ADRA1A—blood—coronary artery disease	0.000686	0.0121	CbGeAlD
Terazosin—KCNH2—blood—coronary artery disease	0.000662	0.0117	CbGeAlD
Terazosin—ABCB1—heart—coronary artery disease	0.000389	0.00689	CbGeAlD
Terazosin—ABCB1—cardiovascular system—coronary artery disease	0.000367	0.0065	CbGeAlD
Terazosin—ABCB1—blood—coronary artery disease	0.000291	0.00514	CbGeAlD
Terazosin—Arthralgia—Timolol—coronary artery disease	0.000117	0.000354	CcSEcCtD
Terazosin—Vomiting—Ezetimibe—coronary artery disease	0.000117	0.000353	CcSEcCtD
Terazosin—Hypersensitivity—Pravastatin—coronary artery disease	0.000117	0.000353	CcSEcCtD
Terazosin—Gastrointestinal pain—Perindopril—coronary artery disease	0.000117	0.000353	CcSEcCtD
Terazosin—Anxiety—Timolol—coronary artery disease	0.000117	0.000353	CcSEcCtD
Terazosin—Angioedema—Lisinopril—coronary artery disease	0.000117	0.000352	CcSEcCtD
Terazosin—Pruritus—Olmesartan—coronary artery disease	0.000117	0.000352	CcSEcCtD
Terazosin—Decreased appetite—Losartan—coronary artery disease	0.000116	0.000352	CcSEcCtD
Terazosin—Abdominal pain—Captopril—coronary artery disease	0.000116	0.000351	CcSEcCtD
Terazosin—Body temperature increased—Captopril—coronary artery disease	0.000116	0.000351	CcSEcCtD
Terazosin—Dizziness—Simvastatin—coronary artery disease	0.000116	0.00035	CcSEcCtD
Terazosin—Rash—Ezetimibe—coronary artery disease	0.000116	0.00035	CcSEcCtD
Terazosin—Dermatitis—Ezetimibe—coronary artery disease	0.000116	0.00035	CcSEcCtD
Terazosin—Confusional state—Ramipril—coronary artery disease	0.000116	0.00035	CcSEcCtD
Terazosin—Discomfort—Timolol—coronary artery disease	0.000116	0.00035	CcSEcCtD
Terazosin—Asthenia—Niacin—coronary artery disease	0.000115	0.000349	CcSEcCtD
Terazosin—Fatigue—Losartan—coronary artery disease	0.000115	0.000349	CcSEcCtD
Terazosin—Headache—Ezetimibe—coronary artery disease	0.000115	0.000348	CcSEcCtD
Terazosin—Malaise—Lisinopril—coronary artery disease	0.000115	0.000348	CcSEcCtD
Terazosin—Anaphylactic shock—Ramipril—coronary artery disease	0.000115	0.000347	CcSEcCtD
Terazosin—Oedema—Ramipril—coronary artery disease	0.000115	0.000347	CcSEcCtD
Terazosin—Vertigo—Lisinopril—coronary artery disease	0.000115	0.000346	CcSEcCtD
Terazosin—Dry mouth—Timolol—coronary artery disease	0.000114	0.000346	CcSEcCtD
Terazosin—Pain—Losartan—coronary artery disease	0.000114	0.000346	CcSEcCtD
Terazosin—Constipation—Losartan—coronary artery disease	0.000114	0.000346	CcSEcCtD
Terazosin—Syncope—Lisinopril—coronary artery disease	0.000114	0.000346	CcSEcCtD
Terazosin—Vomiting—Eplerenone—coronary artery disease	0.000114	0.000346	CcSEcCtD
Terazosin—Feeling abnormal—Furosemide—coronary artery disease	0.000114	0.000346	CcSEcCtD
Terazosin—Nausea—Fenofibrate—coronary artery disease	0.000114	0.000345	CcSEcCtD
Terazosin—Pruritus—Niacin—coronary artery disease	0.000114	0.000344	CcSEcCtD
Terazosin—Asthenia—Pravastatin—coronary artery disease	0.000114	0.000344	CcSEcCtD
Terazosin—Gastrointestinal pain—Furosemide—coronary artery disease	0.000113	0.000343	CcSEcCtD
Terazosin—Rash—Eplerenone—coronary artery disease	0.000113	0.000343	CcSEcCtD
Terazosin—Hypersensitivity—Trandolapril—coronary artery disease	0.000113	0.000343	CcSEcCtD
Terazosin—Dermatitis—Eplerenone—coronary artery disease	0.000113	0.000343	CcSEcCtD
Terazosin—Diarrhoea—Valsartan—coronary artery disease	0.000113	0.000342	CcSEcCtD
Terazosin—Confusional state—Timolol—coronary artery disease	0.000113	0.000342	CcSEcCtD
Terazosin—Shock—Ramipril—coronary artery disease	0.000113	0.000341	CcSEcCtD
Terazosin—Hypersensitivity—Enalapril—coronary artery disease	0.000113	0.000341	CcSEcCtD
Terazosin—Abdominal pain—Perindopril—coronary artery disease	0.000113	0.000341	CcSEcCtD
Terazosin—Body temperature increased—Perindopril—coronary artery disease	0.000113	0.000341	CcSEcCtD
Terazosin—Palpitations—Lisinopril—coronary artery disease	0.000113	0.000341	CcSEcCtD
Terazosin—Diarrhoea—Olmesartan—coronary artery disease	0.000113	0.000341	CcSEcCtD
Terazosin—Headache—Eplerenone—coronary artery disease	0.000113	0.000341	CcSEcCtD
Terazosin—Thrombocytopenia—Ramipril—coronary artery disease	0.000112	0.00034	CcSEcCtD
Terazosin—Anaphylactic shock—Timolol—coronary artery disease	0.000112	0.000339	CcSEcCtD
Terazosin—Oedema—Timolol—coronary artery disease	0.000112	0.000339	CcSEcCtD
Terazosin—Pruritus—Pravastatin—coronary artery disease	0.000112	0.000339	CcSEcCtD
Terazosin—Loss of consciousness—Lisinopril—coronary artery disease	0.000112	0.000339	CcSEcCtD
Terazosin—Nausea—Clopidogrel—coronary artery disease	0.000112	0.000339	CcSEcCtD
Terazosin—Tachycardia—Ramipril—coronary artery disease	0.000112	0.000339	CcSEcCtD
Terazosin—Vomiting—Simvastatin—coronary artery disease	0.000111	0.000337	CcSEcCtD
Terazosin—Hypersensitivity—Telmisartan—coronary artery disease	0.000111	0.000337	CcSEcCtD
Terazosin—Cough—Lisinopril—coronary artery disease	0.000111	0.000336	CcSEcCtD
Terazosin—Nausea—Lovastatin—coronary artery disease	0.000111	0.000336	CcSEcCtD
Terazosin—Hyperhidrosis—Ramipril—coronary artery disease	0.000111	0.000335	CcSEcCtD
Terazosin—Rash—Simvastatin—coronary artery disease	0.000111	0.000334	CcSEcCtD
Terazosin—Dermatitis—Simvastatin—coronary artery disease	0.00011	0.000334	CcSEcCtD
Terazosin—Asthenia—Trandolapril—coronary artery disease	0.00011	0.000334	CcSEcCtD
Terazosin—Shock—Timolol—coronary artery disease	0.00011	0.000334	CcSEcCtD
Terazosin—Feeling abnormal—Losartan—coronary artery disease	0.00011	0.000333	CcSEcCtD
Terazosin—Diarrhoea—Niacin—coronary artery disease	0.00011	0.000333	CcSEcCtD
Terazosin—Asthenia—Enalapril—coronary artery disease	0.00011	0.000332	CcSEcCtD
Terazosin—Headache—Simvastatin—coronary artery disease	0.00011	0.000332	CcSEcCtD
Terazosin—Abdominal pain—Furosemide—coronary artery disease	0.00011	0.000332	CcSEcCtD
Terazosin—Body temperature increased—Furosemide—coronary artery disease	0.00011	0.000332	CcSEcCtD
Terazosin—Gastrointestinal pain—Losartan—coronary artery disease	0.000109	0.000331	CcSEcCtD
Terazosin—Dizziness—Valsartan—coronary artery disease	0.000109	0.000331	CcSEcCtD
Terazosin—Anorexia—Ramipril—coronary artery disease	0.000109	0.000331	CcSEcCtD
Terazosin—Nausea—Ezetimibe—coronary artery disease	0.000109	0.00033	CcSEcCtD
Terazosin—Dizziness—Olmesartan—coronary artery disease	0.000109	0.000329	CcSEcCtD
Terazosin—Pruritus—Trandolapril—coronary artery disease	0.000109	0.000329	CcSEcCtD
Terazosin—Myalgia—Lisinopril—coronary artery disease	0.000109	0.000328	CcSEcCtD
Terazosin—Chest pain—Lisinopril—coronary artery disease	0.000109	0.000328	CcSEcCtD
Terazosin—Arthralgia—Lisinopril—coronary artery disease	0.000109	0.000328	CcSEcCtD
Terazosin—Hyperhidrosis—Timolol—coronary artery disease	0.000108	0.000328	CcSEcCtD
Terazosin—Asthenia—Telmisartan—coronary artery disease	0.000108	0.000328	CcSEcCtD
Terazosin—Pruritus—Enalapril—coronary artery disease	0.000108	0.000328	CcSEcCtD
Terazosin—Diarrhoea—Pravastatin—coronary artery disease	0.000108	0.000328	CcSEcCtD
Terazosin—Anxiety—Lisinopril—coronary artery disease	0.000108	0.000327	CcSEcCtD
Terazosin—Discomfort—Lisinopril—coronary artery disease	0.000107	0.000324	CcSEcCtD
Terazosin—Hypotension—Ramipril—coronary artery disease	0.000107	0.000324	CcSEcCtD
Terazosin—Anorexia—Timolol—coronary artery disease	0.000107	0.000323	CcSEcCtD
Terazosin—Pruritus—Telmisartan—coronary artery disease	0.000107	0.000323	CcSEcCtD
Terazosin—Nausea—Eplerenone—coronary artery disease	0.000107	0.000323	CcSEcCtD
Terazosin—Dizziness—Niacin—coronary artery disease	0.000106	0.000322	CcSEcCtD
Terazosin—Dry mouth—Lisinopril—coronary artery disease	0.000106	0.000321	CcSEcCtD
Terazosin—Body temperature increased—Losartan—coronary artery disease	0.000106	0.00032	CcSEcCtD
Terazosin—Abdominal pain—Losartan—coronary artery disease	0.000106	0.00032	CcSEcCtD
Terazosin—Asthenia—Captopril—coronary artery disease	0.000105	0.000319	CcSEcCtD
Terazosin—Diarrhoea—Trandolapril—coronary artery disease	0.000105	0.000318	CcSEcCtD
Terazosin—Vomiting—Valsartan—coronary artery disease	0.000105	0.000318	CcSEcCtD
Terazosin—Confusional state—Lisinopril—coronary artery disease	0.000105	0.000317	CcSEcCtD
Terazosin—Diarrhoea—Enalapril—coronary artery disease	0.000105	0.000317	CcSEcCtD
Terazosin—Hypotension—Timolol—coronary artery disease	0.000105	0.000317	CcSEcCtD
Terazosin—Dizziness—Pravastatin—coronary artery disease	0.000105	0.000317	CcSEcCtD
Terazosin—Vomiting—Olmesartan—coronary artery disease	0.000105	0.000317	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000105	0.000316	CcSEcCtD
Terazosin—Rash—Valsartan—coronary artery disease	0.000104	0.000315	CcSEcCtD
Terazosin—Dermatitis—Valsartan—coronary artery disease	0.000104	0.000315	CcSEcCtD
Terazosin—Nausea—Simvastatin—coronary artery disease	0.000104	0.000315	CcSEcCtD
Terazosin—Oedema—Lisinopril—coronary artery disease	0.000104	0.000315	CcSEcCtD
Terazosin—Anaphylactic shock—Lisinopril—coronary artery disease	0.000104	0.000315	CcSEcCtD
Terazosin—Pruritus—Captopril—coronary artery disease	0.000104	0.000314	CcSEcCtD
Terazosin—Rash—Olmesartan—coronary artery disease	0.000104	0.000314	CcSEcCtD
Terazosin—Insomnia—Ramipril—coronary artery disease	0.000104	0.000314	CcSEcCtD
Terazosin—Dermatitis—Olmesartan—coronary artery disease	0.000104	0.000314	CcSEcCtD
Terazosin—Headache—Valsartan—coronary artery disease	0.000104	0.000313	CcSEcCtD
Terazosin—Diarrhoea—Telmisartan—coronary artery disease	0.000103	0.000313	CcSEcCtD
Terazosin—Headache—Olmesartan—coronary artery disease	0.000103	0.000312	CcSEcCtD
Terazosin—Paraesthesia—Ramipril—coronary artery disease	0.000103	0.000312	CcSEcCtD
Terazosin—Shock—Lisinopril—coronary artery disease	0.000102	0.00031	CcSEcCtD
Terazosin—Asthenia—Perindopril—coronary artery disease	0.000102	0.00031	CcSEcCtD
Terazosin—Dyspnoea—Ramipril—coronary artery disease	0.000102	0.000309	CcSEcCtD
Terazosin—Vomiting—Niacin—coronary artery disease	0.000102	0.000309	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000102	0.000309	CcSEcCtD
Terazosin—Hypersensitivity—Furosemide—coronary artery disease	0.000102	0.000309	CcSEcCtD
Terazosin—Somnolence—Ramipril—coronary artery disease	0.000102	0.000308	CcSEcCtD
Terazosin—Thrombocytopenia—Lisinopril—coronary artery disease	0.000102	0.000308	CcSEcCtD
Terazosin—Dizziness—Trandolapril—coronary artery disease	0.000102	0.000308	CcSEcCtD
Terazosin—Tachycardia—Lisinopril—coronary artery disease	0.000102	0.000307	CcSEcCtD
Terazosin—Insomnia—Timolol—coronary artery disease	0.000102	0.000307	CcSEcCtD
Terazosin—Rash—Niacin—coronary artery disease	0.000101	0.000307	CcSEcCtD
Terazosin—Dermatitis—Niacin—coronary artery disease	0.000101	0.000306	CcSEcCtD
Terazosin—Dizziness—Enalapril—coronary artery disease	0.000101	0.000306	CcSEcCtD
Terazosin—Dyspepsia—Ramipril—coronary artery disease	0.000101	0.000305	CcSEcCtD
Terazosin—Pruritus—Perindopril—coronary artery disease	0.000101	0.000305	CcSEcCtD
Terazosin—Headache—Niacin—coronary artery disease	0.000101	0.000305	CcSEcCtD
Terazosin—Paraesthesia—Timolol—coronary artery disease	0.000101	0.000305	CcSEcCtD
Terazosin—Vomiting—Pravastatin—coronary artery disease	0.000101	0.000305	CcSEcCtD
Terazosin—Hyperhidrosis—Lisinopril—coronary artery disease	0.000101	0.000304	CcSEcCtD
Terazosin—Diarrhoea—Captopril—coronary artery disease	0.000101	0.000304	CcSEcCtD
Terazosin—Dyspnoea—Timolol—coronary artery disease	0.0001	0.000302	CcSEcCtD
Terazosin—Dizziness—Telmisartan—coronary artery disease	0.0001	0.000302	CcSEcCtD
Terazosin—Rash—Pravastatin—coronary artery disease	9.99e-05	0.000302	CcSEcCtD
Terazosin—Dermatitis—Pravastatin—coronary artery disease	9.98e-05	0.000302	CcSEcCtD
Terazosin—Decreased appetite—Ramipril—coronary artery disease	9.98e-05	0.000302	CcSEcCtD
Terazosin—Somnolence—Timolol—coronary artery disease	9.98e-05	0.000302	CcSEcCtD
Terazosin—Asthenia—Furosemide—coronary artery disease	9.96e-05	0.000301	CcSEcCtD
Terazosin—Headache—Pravastatin—coronary artery disease	9.93e-05	0.0003	CcSEcCtD
Terazosin—Anorexia—Lisinopril—coronary artery disease	9.92e-05	0.0003	CcSEcCtD
Terazosin—Fatigue—Ramipril—coronary artery disease	9.9e-05	0.000299	CcSEcCtD
Terazosin—Dyspepsia—Timolol—coronary artery disease	9.88e-05	0.000299	CcSEcCtD
Terazosin—Hypersensitivity—Losartan—coronary artery disease	9.86e-05	0.000298	CcSEcCtD
Terazosin—Nausea—Valsartan—coronary artery disease	9.83e-05	0.000297	CcSEcCtD
Terazosin—Pruritus—Furosemide—coronary artery disease	9.82e-05	0.000297	CcSEcCtD
Terazosin—Constipation—Ramipril—coronary artery disease	9.82e-05	0.000297	CcSEcCtD
Terazosin—Nausea—Olmesartan—coronary artery disease	9.79e-05	0.000296	CcSEcCtD
Terazosin—Vomiting—Trandolapril—coronary artery disease	9.78e-05	0.000296	CcSEcCtD
Terazosin—Diarrhoea—Perindopril—coronary artery disease	9.77e-05	0.000295	CcSEcCtD
Terazosin—Decreased appetite—Timolol—coronary artery disease	9.76e-05	0.000295	CcSEcCtD
Terazosin—Vomiting—Enalapril—coronary artery disease	9.75e-05	0.000295	CcSEcCtD
Terazosin—Hypotension—Lisinopril—coronary artery disease	9.73e-05	0.000294	CcSEcCtD
Terazosin—Dizziness—Captopril—coronary artery disease	9.72e-05	0.000294	CcSEcCtD
Terazosin—Rash—Trandolapril—coronary artery disease	9.7e-05	0.000293	CcSEcCtD
Terazosin—Dermatitis—Trandolapril—coronary artery disease	9.69e-05	0.000293	CcSEcCtD
Terazosin—Fatigue—Timolol—coronary artery disease	9.68e-05	0.000292	CcSEcCtD
Terazosin—Rash—Enalapril—coronary artery disease	9.66e-05	0.000292	CcSEcCtD
Terazosin—Dermatitis—Enalapril—coronary artery disease	9.66e-05	0.000292	CcSEcCtD
Terazosin—Headache—Trandolapril—coronary artery disease	9.64e-05	0.000291	CcSEcCtD
Terazosin—Vomiting—Telmisartan—coronary artery disease	9.61e-05	0.000291	CcSEcCtD
Terazosin—Asthenia—Losartan—coronary artery disease	9.61e-05	0.00029	CcSEcCtD
Terazosin—Headache—Enalapril—coronary artery disease	9.6e-05	0.00029	CcSEcCtD
Terazosin—Pain—Timolol—coronary artery disease	9.6e-05	0.00029	CcSEcCtD
Terazosin—Nausea—Niacin—coronary artery disease	9.56e-05	0.000289	CcSEcCtD
Terazosin—Rash—Telmisartan—coronary artery disease	9.53e-05	0.000288	CcSEcCtD
Terazosin—Dermatitis—Telmisartan—coronary artery disease	9.52e-05	0.000288	CcSEcCtD
Terazosin—Diarrhoea—Furosemide—coronary artery disease	9.49e-05	0.000287	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Lisinopril—coronary artery disease	9.49e-05	0.000287	CcSEcCtD
Terazosin—Pruritus—Losartan—coronary artery disease	9.47e-05	0.000286	CcSEcCtD
Terazosin—Headache—Telmisartan—coronary artery disease	9.47e-05	0.000286	CcSEcCtD
Terazosin—Feeling abnormal—Ramipril—coronary artery disease	9.46e-05	0.000286	CcSEcCtD
Terazosin—Dizziness—Perindopril—coronary artery disease	9.44e-05	0.000285	CcSEcCtD
Terazosin—Insomnia—Lisinopril—coronary artery disease	9.42e-05	0.000285	CcSEcCtD
Terazosin—Nausea—Pravastatin—coronary artery disease	9.41e-05	0.000285	CcSEcCtD
Terazosin—Gastrointestinal pain—Ramipril—coronary artery disease	9.39e-05	0.000284	CcSEcCtD
Terazosin—Paraesthesia—Lisinopril—coronary artery disease	9.35e-05	0.000283	CcSEcCtD
Terazosin—Vomiting—Captopril—coronary artery disease	9.35e-05	0.000283	CcSEcCtD
Terazosin—Dyspnoea—Lisinopril—coronary artery disease	9.28e-05	0.000281	CcSEcCtD
Terazosin—Rash—Captopril—coronary artery disease	9.27e-05	0.00028	CcSEcCtD
Terazosin—Dermatitis—Captopril—coronary artery disease	9.26e-05	0.00028	CcSEcCtD
Terazosin—Somnolence—Lisinopril—coronary artery disease	9.26e-05	0.00028	CcSEcCtD
Terazosin—Feeling abnormal—Timolol—coronary artery disease	9.25e-05	0.00028	CcSEcCtD
Terazosin—Headache—Captopril—coronary artery disease	9.21e-05	0.000278	CcSEcCtD
Terazosin—Gastrointestinal pain—Timolol—coronary artery disease	9.18e-05	0.000277	CcSEcCtD
Terazosin—Dizziness—Furosemide—coronary artery disease	9.18e-05	0.000277	CcSEcCtD
Terazosin—Dyspepsia—Lisinopril—coronary artery disease	9.16e-05	0.000277	CcSEcCtD
Terazosin—Diarrhoea—Losartan—coronary artery disease	9.16e-05	0.000277	CcSEcCtD
Terazosin—Nausea—Trandolapril—coronary artery disease	9.14e-05	0.000276	CcSEcCtD
Terazosin—Nausea—Enalapril—coronary artery disease	9.1e-05	0.000275	CcSEcCtD
Terazosin—Vomiting—Perindopril—coronary artery disease	9.08e-05	0.000274	CcSEcCtD
Terazosin—Abdominal pain—Ramipril—coronary artery disease	9.07e-05	0.000274	CcSEcCtD
Terazosin—Body temperature increased—Ramipril—coronary artery disease	9.07e-05	0.000274	CcSEcCtD
Terazosin—Decreased appetite—Lisinopril—coronary artery disease	9.05e-05	0.000274	CcSEcCtD
Terazosin—Rash—Perindopril—coronary artery disease	9e-05	0.000272	CcSEcCtD
Terazosin—Dermatitis—Perindopril—coronary artery disease	8.99e-05	0.000272	CcSEcCtD
Terazosin—Nausea—Telmisartan—coronary artery disease	8.98e-05	0.000271	CcSEcCtD
Terazosin—Fatigue—Lisinopril—coronary artery disease	8.98e-05	0.000271	CcSEcCtD
Terazosin—Headache—Perindopril—coronary artery disease	8.94e-05	0.00027	CcSEcCtD
Terazosin—Pain—Lisinopril—coronary artery disease	8.9e-05	0.000269	CcSEcCtD
Terazosin—Constipation—Lisinopril—coronary artery disease	8.9e-05	0.000269	CcSEcCtD
Terazosin—Abdominal pain—Timolol—coronary artery disease	8.87e-05	0.000268	CcSEcCtD
Terazosin—Body temperature increased—Timolol—coronary artery disease	8.87e-05	0.000268	CcSEcCtD
Terazosin—Dizziness—Losartan—coronary artery disease	8.85e-05	0.000268	CcSEcCtD
Terazosin—Vomiting—Furosemide—coronary artery disease	8.82e-05	0.000267	CcSEcCtD
Terazosin—Rash—Furosemide—coronary artery disease	8.75e-05	0.000264	CcSEcCtD
Terazosin—Dermatitis—Furosemide—coronary artery disease	8.74e-05	0.000264	CcSEcCtD
Terazosin—Nausea—Captopril—coronary artery disease	8.73e-05	0.000264	CcSEcCtD
Terazosin—Headache—Furosemide—coronary artery disease	8.69e-05	0.000263	CcSEcCtD
Terazosin—Feeling abnormal—Lisinopril—coronary artery disease	8.58e-05	0.000259	CcSEcCtD
Terazosin—Gastrointestinal pain—Lisinopril—coronary artery disease	8.51e-05	0.000257	CcSEcCtD
Terazosin—Vomiting—Losartan—coronary artery disease	8.51e-05	0.000257	CcSEcCtD
Terazosin—Nausea—Perindopril—coronary artery disease	8.48e-05	0.000256	CcSEcCtD
Terazosin—Hypersensitivity—Ramipril—coronary artery disease	8.46e-05	0.000256	CcSEcCtD
Terazosin—Rash—Losartan—coronary artery disease	8.44e-05	0.000255	CcSEcCtD
Terazosin—Dermatitis—Losartan—coronary artery disease	8.43e-05	0.000255	CcSEcCtD
Terazosin—Headache—Losartan—coronary artery disease	8.39e-05	0.000253	CcSEcCtD
Terazosin—Hypersensitivity—Timolol—coronary artery disease	8.27e-05	0.00025	CcSEcCtD
Terazosin—Nausea—Furosemide—coronary artery disease	8.24e-05	0.000249	CcSEcCtD
Terazosin—Asthenia—Ramipril—coronary artery disease	8.24e-05	0.000249	CcSEcCtD
Terazosin—Abdominal pain—Lisinopril—coronary artery disease	8.23e-05	0.000249	CcSEcCtD
Terazosin—Body temperature increased—Lisinopril—coronary artery disease	8.23e-05	0.000249	CcSEcCtD
Terazosin—Pruritus—Ramipril—coronary artery disease	8.12e-05	0.000245	CcSEcCtD
Terazosin—Asthenia—Timolol—coronary artery disease	8.05e-05	0.000243	CcSEcCtD
Terazosin—Nausea—Losartan—coronary artery disease	7.95e-05	0.00024	CcSEcCtD
Terazosin—Pruritus—Timolol—coronary artery disease	7.94e-05	0.00024	CcSEcCtD
Terazosin—Diarrhoea—Ramipril—coronary artery disease	7.85e-05	0.000237	CcSEcCtD
Terazosin—Diarrhoea—Timolol—coronary artery disease	7.68e-05	0.000232	CcSEcCtD
Terazosin—Hypersensitivity—Lisinopril—coronary artery disease	7.67e-05	0.000232	CcSEcCtD
Terazosin—Dizziness—Ramipril—coronary artery disease	7.59e-05	0.000229	CcSEcCtD
Terazosin—Asthenia—Lisinopril—coronary artery disease	7.47e-05	0.000226	CcSEcCtD
Terazosin—Dizziness—Timolol—coronary artery disease	7.42e-05	0.000224	CcSEcCtD
Terazosin—Pruritus—Lisinopril—coronary artery disease	7.37e-05	0.000223	CcSEcCtD
Terazosin—Vomiting—Ramipril—coronary artery disease	7.3e-05	0.000221	CcSEcCtD
Terazosin—Rash—Ramipril—coronary artery disease	7.24e-05	0.000219	CcSEcCtD
Terazosin—Dermatitis—Ramipril—coronary artery disease	7.23e-05	0.000219	CcSEcCtD
Terazosin—Headache—Ramipril—coronary artery disease	7.19e-05	0.000217	CcSEcCtD
Terazosin—Vomiting—Timolol—coronary artery disease	7.14e-05	0.000216	CcSEcCtD
Terazosin—Diarrhoea—Lisinopril—coronary artery disease	7.12e-05	0.000215	CcSEcCtD
Terazosin—Rash—Timolol—coronary artery disease	7.08e-05	0.000214	CcSEcCtD
Terazosin—Dermatitis—Timolol—coronary artery disease	7.07e-05	0.000214	CcSEcCtD
Terazosin—Headache—Timolol—coronary artery disease	7.03e-05	0.000212	CcSEcCtD
Terazosin—Dizziness—Lisinopril—coronary artery disease	6.88e-05	0.000208	CcSEcCtD
Terazosin—Nausea—Ramipril—coronary artery disease	6.82e-05	0.000206	CcSEcCtD
Terazosin—Nausea—Timolol—coronary artery disease	6.67e-05	0.000201	CcSEcCtD
Terazosin—Vomiting—Lisinopril—coronary artery disease	6.62e-05	0.0002	CcSEcCtD
Terazosin—Rash—Lisinopril—coronary artery disease	6.56e-05	0.000198	CcSEcCtD
Terazosin—Dermatitis—Lisinopril—coronary artery disease	6.56e-05	0.000198	CcSEcCtD
Terazosin—Headache—Lisinopril—coronary artery disease	6.52e-05	0.000197	CcSEcCtD
Terazosin—Nausea—Lisinopril—coronary artery disease	6.18e-05	0.000187	CcSEcCtD
Terazosin—ADRA1B—Signaling by GPCR—CREB1—coronary artery disease	1.08e-05	8.64e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AGTR1—coronary artery disease	1.08e-05	8.62e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALDOA—coronary artery disease	1.08e-05	8.62e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CSF2—coronary artery disease	1.07e-05	8.61e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—FGF1—coronary artery disease	1.07e-05	8.61e-05	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.07e-05	8.56e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—LPL—coronary artery disease	1.07e-05	8.54e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CXCL12—coronary artery disease	1.06e-05	8.47e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—RPS6KB1—coronary artery disease	1.06e-05	8.47e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—BDKRB2—coronary artery disease	1.06e-05	8.47e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MEF2C—coronary artery disease	1.06e-05	8.47e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCL2—coronary artery disease	1.06e-05	8.46e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—POMC—coronary artery disease	1.06e-05	8.45e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL6R—coronary artery disease	1.05e-05	8.43e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—F2—coronary artery disease	1.05e-05	8.43e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CXCL10—coronary artery disease	1.05e-05	8.42e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PLG—coronary artery disease	1.05e-05	8.4e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL6ST—coronary artery disease	1.05e-05	8.39e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—DCN—coronary artery disease	1.04e-05	8.36e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—JUNB—coronary artery disease	1.04e-05	8.31e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PLCB1—coronary artery disease	1.03e-05	8.28e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ITGB3—coronary artery disease	1.03e-05	8.25e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ADRB2—coronary artery disease	1.02e-05	8.18e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALDH2—coronary artery disease	1.02e-05	8.14e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR7—coronary artery disease	1.01e-05	8.11e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PRKCE—coronary artery disease	1.01e-05	8.07e-05	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—JAK2—coronary artery disease	1.01e-05	8.07e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CXCL8—coronary artery disease	1.01e-05	8.06e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SOCS1—coronary artery disease	1.01e-05	8.05e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—S100B—coronary artery disease	1e-05	8.03e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PPP2CA—coronary artery disease	1e-05	8.02e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SOCS3—coronary artery disease	9.93e-06	7.95e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP2C19—coronary artery disease	9.9e-06	7.93e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3C2A—coronary artery disease	9.9e-06	7.93e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—LIPC—coronary artery disease	9.9e-06	7.93e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—HBA1—coronary artery disease	9.9e-06	7.93e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOC3—coronary artery disease	9.84e-06	7.88e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PRKCD—coronary artery disease	9.83e-06	7.87e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TGFBR2—coronary artery disease	9.81e-06	7.86e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—KITLG—coronary artery disease	9.81e-06	7.86e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—LDLR—coronary artery disease	9.78e-06	7.83e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GSTT1—coronary artery disease	9.66e-06	7.74e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SLC9A1—coronary artery disease	9.66e-06	7.74e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ITGAV—coronary artery disease	9.65e-06	7.73e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—KNG1—coronary artery disease	9.62e-06	7.7e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HTR2A—coronary artery disease	9.62e-06	7.7e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—C3—coronary artery disease	9.6e-06	7.69e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—STAT5A—coronary artery disease	9.59e-06	7.68e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MMP3—coronary artery disease	9.59e-06	7.68e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—POMC—coronary artery disease	9.58e-06	7.68e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CREB1—coronary artery disease	9.58e-06	7.68e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AGTR1—coronary artery disease	9.56e-06	7.66e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GCLC—coronary artery disease	9.55e-06	7.65e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CETP—coronary artery disease	9.55e-06	7.65e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SDC1—coronary artery disease	9.44e-06	7.56e-05	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	9.38e-06	7.51e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCL2—coronary artery disease	9.38e-06	7.51e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL6R—coronary artery disease	9.35e-06	7.49e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CXCL10—coronary artery disease	9.34e-06	7.48e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PLG—coronary artery disease	9.32e-06	7.46e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APOB—coronary artery disease	9.27e-06	7.43e-05	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CXCL8—coronary artery disease	9.19e-06	7.36e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HIF1A—coronary artery disease	9.16e-06	7.34e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—JAK2—coronary artery disease	9.15e-06	7.33e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AGT—coronary artery disease	9.12e-06	7.31e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—EDN1—coronary artery disease	9.12e-06	7.31e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ADRB2—coronary artery disease	9.07e-06	7.26e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCL5—coronary artery disease	9.05e-06	7.25e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PRKCE—coronary artery disease	8.95e-06	7.17e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—JAK2—coronary artery disease	8.95e-06	7.17e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APOE—coronary artery disease	8.94e-06	7.16e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—LEP—coronary artery disease	8.94e-06	7.16e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SOCS1—coronary artery disease	8.93e-06	7.15e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PSMB5—coronary artery disease	8.92e-06	7.15e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PSMA6—coronary artery disease	8.92e-06	7.15e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CSF2—coronary artery disease	8.92e-06	7.14e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FGF1—coronary artery disease	8.92e-06	7.14e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—S100B—coronary artery disease	8.91e-06	7.14e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—LPL—coronary artery disease	8.85e-06	7.09e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APOA1—coronary artery disease	8.84e-06	7.08e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SOCS3—coronary artery disease	8.82e-06	7.07e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MEF2C—coronary artery disease	8.77e-06	7.03e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—RPS6KB1—coronary artery disease	8.77e-06	7.03e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—KDR—coronary artery disease	8.76e-06	7.02e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TGFBR2—coronary artery disease	8.72e-06	6.98e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—KITLG—coronary artery disease	8.72e-06	6.98e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CTGF—coronary artery disease	8.72e-06	6.98e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MAPK14—coronary artery disease	8.7e-06	6.97e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GOT2—coronary artery disease	8.64e-06	6.92e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—HMGCR—coronary artery disease	8.64e-06	6.92e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ITGB3—coronary artery disease	8.55e-06	6.85e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ESR1—coronary artery disease	8.53e-06	6.84e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—STAT5A—coronary artery disease	8.52e-06	6.82e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MMP3—coronary artery disease	8.52e-06	6.82e-05	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	8.47e-06	6.78e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—FN1—coronary artery disease	8.43e-06	6.75e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—F2—coronary artery disease	8.43e-06	6.75e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL6ST—coronary artery disease	8.4e-06	6.73e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CXCL8—coronary artery disease	8.35e-06	6.69e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NFKBIA—coronary artery disease	8.33e-06	6.67e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PPP2CA—coronary artery disease	8.31e-06	6.65e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APOB—coronary artery disease	8.23e-06	6.6e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CXCL8—coronary artery disease	8.16e-06	6.54e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PRKCD—coronary artery disease	8.16e-06	6.53e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—JAK2—coronary artery disease	8.12e-06	6.51e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—EDN1—coronary artery disease	8.1e-06	6.49e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—KIT—coronary artery disease	8.07e-06	6.46e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCL5—coronary artery disease	8.04e-06	6.44e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HTR2A—coronary artery disease	7.98e-06	6.39e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—C3—coronary artery disease	7.97e-06	6.38e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PLCB1—coronary artery disease	7.94e-06	6.36e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FGF1—coronary artery disease	7.92e-06	6.34e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CSF2—coronary artery disease	7.92e-06	6.34e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—LPL—coronary artery disease	7.86e-06	6.3e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—RPS6KB1—coronary artery disease	7.79e-06	6.24e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MEF2C—coronary artery disease	7.79e-06	6.24e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GSK3B—coronary artery disease	7.74e-06	6.2e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ABCA1—coronary artery disease	7.7e-06	6.17e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—POMC—coronary artery disease	7.68e-06	6.15e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CREB1—coronary artery disease	7.68e-06	6.15e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HIF1A—coronary artery disease	7.6e-06	6.09e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ITGB3—coronary artery disease	7.59e-06	6.08e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AGT—coronary artery disease	7.57e-06	6.07e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCL2—coronary artery disease	7.51e-06	6.02e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL6R—coronary artery disease	7.49e-06	6e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GGT1—coronary artery disease	7.46e-06	5.97e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GOT1—coronary artery disease	7.46e-06	5.97e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—LEP—coronary artery disease	7.42e-06	5.94e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APOE—coronary artery disease	7.42e-06	5.94e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CXCL8—coronary artery disease	7.41e-06	5.94e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IGF1—coronary artery disease	7.39e-06	5.92e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PPP2CA—coronary artery disease	7.38e-06	5.91e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—MAPK1—coronary artery disease	7.35e-06	5.89e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APOA1—coronary artery disease	7.33e-06	5.88e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—KDR—coronary artery disease	7.27e-06	5.82e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PRKCD—coronary artery disease	7.24e-06	5.8e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MAPK14—coronary artery disease	7.22e-06	5.78e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR2A—coronary artery disease	7.09e-06	5.68e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ESR1—coronary artery disease	7.08e-06	5.67e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—C3—coronary artery disease	7.08e-06	5.67e-05	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PIK3CA—coronary artery disease	7.03e-06	5.63e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SERPINE1—coronary artery disease	7.01e-06	5.62e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—F2—coronary artery disease	7e-06	5.6e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FN1—coronary artery disease	7e-06	5.6e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL6ST—coronary artery disease	6.97e-06	5.58e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NFKBIA—coronary artery disease	6.91e-06	5.54e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—FGF2—coronary artery disease	6.79e-06	5.44e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HIF1A—coronary artery disease	6.75e-06	5.41e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AGT—coronary artery disease	6.73e-06	5.39e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GSTP1—coronary artery disease	6.7e-06	5.36e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NOS3—coronary artery disease	6.7e-06	5.36e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—KIT—coronary artery disease	6.7e-06	5.36e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PPARGC1A—coronary artery disease	6.64e-06	5.32e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—HMOX1—coronary artery disease	6.61e-06	5.29e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—LEP—coronary artery disease	6.59e-06	5.28e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APOE—coronary artery disease	6.59e-06	5.28e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CAT—coronary artery disease	6.52e-06	5.22e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APOA1—coronary artery disease	6.52e-06	5.22e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—JAK2—coronary artery disease	6.51e-06	5.21e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—KDR—coronary artery disease	6.46e-06	5.17e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GSK3B—coronary artery disease	6.43e-06	5.15e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MAPK14—coronary artery disease	6.41e-06	5.14e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PIK3CA—coronary artery disease	6.38e-06	5.11e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—POMC—coronary artery disease	6.37e-06	5.11e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CREB1—coronary artery disease	6.37e-06	5.11e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOB—coronary artery disease	6.33e-06	5.07e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ESR1—coronary artery disease	6.29e-06	5.04e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCL2—coronary artery disease	6.24e-06	5e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL6R—coronary artery disease	6.22e-06	4.98e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—F2—coronary artery disease	6.22e-06	4.98e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FN1—coronary artery disease	6.22e-06	4.98e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL6ST—coronary artery disease	6.19e-06	4.96e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GSTM1—coronary artery disease	6.15e-06	4.93e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NFKBIA—coronary artery disease	6.14e-06	4.92e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IGF1—coronary artery disease	6.13e-06	4.91e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—MAPK1—coronary artery disease	6.1e-06	4.89e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—LPL—coronary artery disease	6.04e-06	4.84e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—KIT—coronary artery disease	5.95e-06	4.76e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CXCL8—coronary artery disease	5.94e-06	4.76e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GPX1—coronary artery disease	5.89e-06	4.72e-05	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PIK3CA—coronary artery disease	5.83e-06	4.67e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SERPINE1—coronary artery disease	5.82e-06	4.66e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CD36—coronary artery disease	5.74e-06	4.6e-05	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—AKT1—coronary artery disease	5.74e-06	4.6e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GSK3B—coronary artery disease	5.71e-06	4.57e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CASP3—coronary artery disease	5.69e-06	4.55e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PPP2CA—coronary artery disease	5.67e-06	4.54e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—POMC—coronary artery disease	5.66e-06	4.53e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CREB1—coronary artery disease	5.66e-06	4.53e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL6—coronary artery disease	5.65e-06	4.52e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FGF2—coronary artery disease	5.64e-06	4.51e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NOS3—coronary artery disease	5.56e-06	4.45e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCL2—coronary artery disease	5.54e-06	4.44e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCND1—coronary artery disease	5.53e-06	4.43e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL6R—coronary artery disease	5.52e-06	4.42e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IGF1—coronary artery disease	5.45e-06	4.36e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—MTHFR—coronary artery disease	5.44e-06	4.36e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—MAPK1—coronary artery disease	5.42e-06	4.34e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—JAK2—coronary artery disease	5.4e-06	4.33e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MMP9—coronary artery disease	5.37e-06	4.3e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3CA—coronary artery disease	5.29e-06	4.24e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—AKT1—coronary artery disease	5.21e-06	4.17e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	5.18e-06	4.15e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	5.17e-06	4.14e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AGT—coronary artery disease	5.17e-06	4.14e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOE—coronary artery disease	5.06e-06	4.06e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	5.01e-06	4.01e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOA1—coronary artery disease	5.01e-06	4.01e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	4.94e-06	3.95e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	4.93e-06	3.95e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—VEGFA—coronary artery disease	4.83e-06	3.86e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	4.8e-06	3.84e-05	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	4.76e-06	3.82e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	4.72e-06	3.78e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	4.7e-06	3.77e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	4.69e-06	3.76e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	4.59e-06	3.68e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	4.46e-06	3.57e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TGFB1—coronary artery disease	4.43e-06	3.55e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PPARG—coronary artery disease	4.41e-06	3.53e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	4.38e-06	3.51e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—POMC—coronary artery disease	4.35e-06	3.48e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MAPK1—coronary artery disease	4.34e-06	3.48e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	4.33e-06	3.46e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	4.23e-06	3.39e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	4.19e-06	3.36e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	4.16e-06	3.34e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	4.08e-06	3.27e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	4e-06	3.21e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALB—coronary artery disease	3.97e-06	3.18e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	3.96e-06	3.17e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	3.84e-06	3.08e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NOS3—coronary artery disease	3.79e-06	3.04e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CA—coronary artery disease	3.77e-06	3.02e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	3.68e-06	2.94e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	3.6e-06	2.89e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	3.56e-06	2.85e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTGS2—coronary artery disease	3.47e-06	2.78e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL6—coronary artery disease	3.34e-06	2.67e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	3.26e-06	2.62e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	3.2e-06	2.56e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	3.13e-06	2.51e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AKT1—coronary artery disease	3.08e-06	2.47e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	2.78e-06	2.23e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL6—coronary artery disease	2.77e-06	2.22e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	2.56e-06	2.05e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL6—coronary artery disease	2.46e-06	1.97e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	2.27e-06	1.82e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CA—coronary artery disease	2.13e-06	1.71e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AKT1—coronary artery disease	1.74e-06	1.4e-05	CbGpPWpGaD
